Levocetirizine & Montelukast Dispersible Tablets Manufacturer & Exporter India

Product Overview
Key Features
Therapeutic Uses
Dosage Form Advantages

Levocetirizine & Montelukast Dispersible Tablets are combination antiallergic formulations used for the effective management of allergic rhinitis, chronic urticaria, and associated respiratory allergic conditions. This combination works synergistically, where Levocetirizine blocks peripheral H1 receptors to control histamine-mediated symptoms, and Montelukast acts as a leukotriene receptor antagonist to reduce inflammation and airway sensitivity.

The dispersible tablet form allows quick dissolution in water, making it highly suitable for pediatric and geriatric patients, as well as individuals who have difficulty swallowing conventional tablets. This combination therapy provides comprehensive allergy control with improved patient compliance.

Genliva Wellness LLP is a trusted levocetirizine montelukast tablets manufacturer India, offering high-quality formulations for domestic markets, exports, and third party pharma manufacturing India services.

Levocetirizine and Montelukast dispersible tablets combine an antihistamine with a leukotriene receptor antagonist to provide comprehensive allergy control. The dispersible format allows quick administration and faster onset, especially suitable for pediatric and easy-to-swallow needs.

Dual-action formula targeting histamine and leukotriene pathways
Helps control both early and late-phase allergic responses
Dispersible tablet for quick dissolution in water or mouth
Suitable for pediatric and sensitive patient groups
Provides effective relief with improved patient convenience
Manufactured under controlled quality and compliance standards

This combination is widely used in the management of allergic conditions involving respiratory and nasal symptoms. It helps reduce inflammation and improves breathing comfort.

Allergic rhinitis (seasonal and perennial)
Sneezing, runny nose, and nasal congestion
Allergic cough and airway inflammation
Supportive therapy in asthma and bronchial allergies
Relief from watery eyes and throat irritation

The formulation is designed to deliver effective allergy relief with enhanced convenience and compliance. It supports consistent therapeutic action and ease of administration.

Fast-dissolving format for quick onset of action
Improved patient compliance, especially in children
No need for swallowing whole tablets
Provides combined anti-allergic and anti-inflammatory benefits
Stable formulation with reliable performance
Suitable for large-scale supply and global distribution